# FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin

- Link: https://www.thailand-business-news.com/pr-news/fibersense-continuous-glucose-monitoring-cgm-system-obtains-ce-mark-as-commercial-launch-preparations-begin
- Published: 2026-06-17T16:06:00+07:00
- Author: PR Newswire

|   |

**_Major regulatory milestone paves the way for commercialization and marks first
step toward broader CxM biomarker sensing strategy_**

BASEL, Switzerland, June 17, 2026 /PRNewswire/ — FiberSense AG ("FiberSense") today
announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained
CE marking under Regulation (EU) 2017/745 as a Class IIb medical device.

 [⌊FiberSense obtains CE marking for its new CGM System, designed to support continuous glucose monitoring in everyday life⌉](https://mma.prnasia.com/media2/2997049/FiberSense_CE_marking_CGM.jpg?p=medium600)

FiberSense obtains CE marking for its new CGM System, designed to support continuous
glucose monitoring in everyday life

The system is intended for the continuous monitoring of blood sugar levels and glucose
trends in adults with diabetes. Based on advanced optical sensing technology, it
measures glucose concentrations in the tissue fluid beneath the skin.

To support longer wear and reduce routine replacements, the system’s optical sensor
and overtape can be worn for up to 28 days before replacement, while the detector
and charger have been designed for repeat use.

"This certification is a defining milestone for FiberSense," said Michael Tillmann,
Chairman & CEO of FiberSense AG. "After years of dedicated development, our focus
now turns to manufacturing scale-up and commercialization."

With CE marking achieved, FiberSense is now advancing the transition from regulatory
certification to commercial readiness. The company is preparing manufacturing ramp-
up, logistics, customer support and market access activities for selected launch
markets, with initial orders already confirmed and first deliveries expected in 
late 2026.

Continuous glucose monitoring is the first regulated application of FiberSense’s
planned continuous multi-analyte ("CxM") platform. While the current approved intended
use is continuous glucose monitoring in adults with diabetes, FiberSense continues
to advance its CxM pipeline, with ketones, lactate and cortisol among the next sensor
targets under evaluation.

"The FiberSense CGM System represents the first regulated application of our long-
term strategy," Tillmann commented. "The goal is to explore additional opportunities
in continuous biomarker sensing beyond glucose and develop a platform solution that
may one day support additional analytes and applications, provided it is supported
by the necessary scientific, clinical and regulatory evidence."

**Contact FiberSense **

+49 (0)6026 942 121
[media@fibersense-cxm.com](https://www.thailand-business-news.com/pr-news/media@fibersense-cxm.com)
[www.fibersense-cxm.com](http://www.fibersense-cxm.com/)

**About FiberSense**

FiberSense AG, headquartered in Basel, Switzerland, is an optical biomarker sensing
company focused on health and medical technology. Building on the experience of 
EyeSense, a spin-off from CIBA Vision, formerly part of Novartis, FiberSense combines
optical sensing expertise with the ambition to develop innovative, long-wear monitoring
solutions for everyday use.

**Regulatory and forward-looking note**
The FiberSense CGM System is a CE-marked
Class IIb medical device under Regulation (EU) 2017/745 and is intended for continuous
glucose monitoring in adults with diabetes in accordance with the Instructions for
Use. Product availability, first deliveries and future applications beyond glucose
remain subject to applicable regulatory, quality, manufacturing, commercial and 
market-specific requirements.

 

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin ](http://www.prnasia.com/story/archive/4985511_AE85511_0?rand=184833)
